Medicine & Life Sciences

1. Alberta 5%
2. Biological Factors 13%
3. Biological Products 11%
4. Biological Therapy 12%
5. Biomarkers 5%
6. Canada 15%
7. Child 7%
8. Cohort Studies 11%
9. Confidence Intervals 9%
10. Costs and Cost Analysis 6%
11. Crohn Disease 50%
12. Drug Monitoring 5%
13. Flax 16%
14. Gastroenterologists 9%
15. Gastroenterology 18%
16. Health 5%
17. Health Care Costs 5%
18. Hospitalization 9%
19. Immunization 8%
20. Immunomodulation 5%
21. Immunosuppressive Agents 6%
22. Inactivated Vaccines 6%
23. Incidence 8%
24. Inflammation 7%
25. Inflammatory Bowel Disease 2 10%
26. Inflammatory Bowel Diseases 100%
27. Lignans 14%
28. Manitoba 8%
29. Micronutrients 5%
30. Patient Acceptance of Health Care 6%
31. Patient Reported Outcome Measures 5%
32. Pediatrics 8%
33. Pharmaceutical Preparations 5%
34. Physicians 5%
35. Placebos 12%
36. Population 21%
37. Practice Guidelines 19%
38. Practice Management 6%
39. Pyruvate Kinase 6%
40. Randomized Controlled Trials 8%
41. rhuMAb Beta7 20%
42. Safety 6%
43. secoisolariciresinol diglucoside 6%
44. Therapeutics 12%
45. Tumor Necrosis Factor Inhibitors 8%
46. Tumor Necrosis Factor-alpha 11%
47. Ulcerative Colitis 27%
48. Ustekinumab 9%
49. Venous Thromboembolism 5%
50. Vitamin D 8%